Sun Pharmaceutical Industries Limited has reported Consolidated financial results for the period ended June 30, 2022. Financial Results (Q1 FY2023) - QoQ Comparison The company has reported total income of Rs. 10763.90 crores during the period ended June 30, 2022 as compared to Rs. 9560.35 crores during the period ended March 31, 2022. The company has posted net profit / (loss) of Rs. 2060.88 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. -2277.25 crores for the period ended March 31, 2022. The company has reported EPS of Rs. 8.6 for the period ended June 30, 2022 as compared to Rs. -9.5 for the period ended March 31, 2022. Financials Q1 FY2023 Q4 FY2022 % Change Total Income ₹ 10763.90 crs ₹9560.35 crs 12.59% Net Profit ₹2060.88 crs ₹-2277.25 crs 190.50% EPS ₹8.6 ₹-9.5 190.53% Financial Results (Q1 FY2023) - YoY Comparison The company has reported total income of Rs. 10763.90 crores during the period ended June 30, 2022 as compared to Rs.9871.26 crores during the period ended June 30, 2021. The company has posted net profit / (loss) of Rs.2060.88 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.1444.17 crores for the period ended June 30, 2021. The company has reported EPS of Rs.8.6 for the period ended June 30, 2022 as compared to Rs.6 for the period ended June 30, 2021. Financials Q1 FY2023 Q1 FY2022 % Change Total Income ₹ 10763.90 crs ₹9871.26 crs 9.04% Net Profit ₹2060.88 crs ₹1444.17 crs 42.70% EPS ₹8.6 ₹6 43.33% Shares of Sun Pharmaceutical Industries Limited was last trading in BSE at Rs. 894.75 as compared to the previous close of Rs. 895.50. The total number of shares traded during the day was 95988 in over 3852 trades. The stock hit an intraday high of Rs. 896.25 and intraday low of 879.00. The net turnover during the day was Rs. 85413225.00.

Website Created & Maintained by : Chennai Scripts West Mambalam, Chennai - 600 033, Tamil Nadu, India